文献检索/Expert Opinion on Drug SafetyEM-T3Expert Opinion on Drug Safety2019-11-26第 19 卷第 2 期，211-221开放获取高影响力 · 前 10%Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance studyKohei KakuKawasaki Medical SchoolRina ChinEli Lilly (Japan)Yusuke NaitoBoehringer Ingelheim (Japan)Hristo IlievBoehringer Ingelheim (Germany)Rie IkedaBoehringer Ingelheim (Japan)Kaori OchiaiAtsutaka YasuiBoehringer Ingelheim (Japan)开放获取全文去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词empagliflozinSGLT2 inhibitorstype 2 diabetesadverse drug reactionsdrug safetyreal-world effectivenesspost-marketing surveillanceJapanese patientshypoglycemiaurinary tract infectiondiabetic ketoacidosislower limb amputationhypovolemiarenal dysfunctionliver dysfunction参考文献24引证文献2相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
